Parkinson's Disease and Experiences Throughout the COVID-19 Pandemic
Does Locus of Control Affect Satisfaction and Quality of Life During COVID - 19?
1 other identifier
observational
150
1 country
1
Brief Summary
The purpose of this research study is to examine the relationship between personal characteristics and satisfaction with care in those diagnosed with Parkinson's disease during the COVID-19 pandemic. Participants will take 4 different surveys regarding their satisfaction with care throughout the duration of the COVID-19 pandemic. The surveys in total should not take more than 30 minutes to complete
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 14, 2021
CompletedFirst Posted
Study publicly available on registry
January 22, 2021
CompletedStudy Start
First participant enrolled
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2021
CompletedApril 1, 2021
March 1, 2021
1 month
January 14, 2021
March 30, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Measure of the relationship between Locus of Control and Quality of Life
Participants will take the Multidimensional Health Locus of Control (MHLC) Scale. This will determine if the participant has more of an internal or external locus of control. Participants will also take the Quality of Life Scale- U.S Parkinson's Disease Questionnaire (PDQ-39) to determine the quality of life they have been experiencing throughout the COVID-19 pandemic. Based on the results of both surveys, the researchers will be able to determine if external locus of control or internal locus of control leads to a better quality of life in PD patients throughout the COVID-19 pandemic.
1 year
Measure of secondary control and satisfaction with care
Participants will take the Multidimensional Health Locus Control (MHLC) scale. This will determine what type of control is most present in the participant's life. Additionally, participant's will take the Short Form Patient Satisfaction Questionnaire (PSQ-18). This will determine how satisfied participants are with their healthcare providers throughout the COVID-19 pandemic. Based off of the responses to the surveys, the researcher will be able to determine whether a higher or lower secondary control yields a higher satisfaction.
1 year
Interventions
There is no intervention for this study.
Eligibility Criteria
The study population is people, 18 years or older, who are diagnosed with Parkinson's disease.
You may qualify if:
- years or older
- Diagnosed with Parkinson's Disease
- Must be able to complete the surveys without any help
You may not qualify if:
- Under the age of 18
- Not diagnosed with Parkinson's Disease
- Unable to complete the surveys without help
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Towson University
Towson, Maryland, 21204, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Graduate Student
Study Record Dates
First Submitted
January 14, 2021
First Posted
January 22, 2021
Study Start
March 1, 2021
Primary Completion
April 1, 2021
Study Completion
May 1, 2021
Last Updated
April 1, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share